Advertisement

NewsPfizer-BioNTech

Pfizer-BioNTech News

09 Dec 2021

"Three doses of Pfizer-BioNTech COVID-19 vaccine neutralises Omicron variant"

Results from the study revealed that serum antibody induced by the Pfizer-BioNTech COVID-19 vaccine neutralises the Omicron variant after three doses. Data indicated that the third dose of vaccine increased the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant.

13 Jul 2021

Document for emergency use listing of Covaxin submitted to WHO: Bharat Biotech

WHO has approved vaccines Pfizer-BioNTech, AstraZeneca- SK Bio/SII, Johnson & Johnson Janssen, Moderna, and Sinopharm for emergency use The trial was conducted on 25,800 subjects, and the data submitted to the Subject Expert Committee (SEC) showed the vaccine was “well-tolerated”

18 Jun 2021

Get Pfizer or Moderna for second jab after receiving AstraZeneca vaccine: NACI

There are two mRNA vaccines currently approved for use in Canada produced by Pfizer-BioNTech and Moderna NACI said the mixed-dose schedule provides better protection against the disease

23 May 2021

UK launches 3rd booster dose trial of 7 COVID vax

The trial will assess COVID-19 vaccines of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac Cov-Boost, aims to begin in June and recruit 3,000 people of all ages who had their first dose in December or January

Loading...

NEWS ON ONE CLICK